Published in Eur J Hum Genet on March 09, 2011
Premature ovarian failure: a critical condition in the reproductive potential with various genetic causes. Int J Fertil Steril (2014) 0.83
Instability in X chromosome inactivation patterns in AMD: a new risk factor? Med Hypothesis Discov Innov Ophthalmol (2013) 0.75
Complement factor H polymorphism in age-related macular degeneration. Science (2005) 31.10
Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. Mol Biol Evol (1995) 30.55
Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol (2004) 18.86
The International HapMap Project Web site. Genome Res (2005) 5.96
Age-related macular degeneration. N Engl J Med (2006) 5.06
Transmission/disequilibrium tests for extended marker haplotypes. Am J Hum Genet (1999) 4.07
On the identification of disease mutations by the analysis of haplotype similarity and goodness of fit. Am J Hum Genet (2003) 3.16
Testing for association on the X chromosome. Biostatistics (2008) 2.55
The X chromosome in population genetics. Nat Rev Genet (2004) 2.47
Association mapping via regularized regression analysis of single-nucleotide-polymorphism haplotypes in variable-sized sliding windows. Am J Hum Genet (2007) 2.04
Transmission/disequilibrium test based on haplotype sharing for tightly linked markers. Am J Hum Genet (2003) 1.84
Data mining applied to linkage disequilibrium mapping. Am J Hum Genet (2000) 1.78
Dry eye signs and symptoms in women with premature ovarian failure. Arch Ophthalmol (2004) 1.69
Search for multifactorial disease susceptibility genes in founder populations. Ann Hum Genet (2000) 1.66
Testing association for markers on the X chromosome. Genet Epidemiol (2007) 1.43
X-chromosome as a marker for population history: linkage disequilibrium and haplotype study in Eurasian populations. Eur J Hum Genet (2005) 0.97
Angiotensin-converting-enzyme inhibition in stable coronary artery disease. N Engl J Med (2004) 9.67
A pharmacogenetic versus a clinical algorithm for warfarin dosing. N Engl J Med (2013) 7.09
Mitral-valve repair versus replacement for severe ischemic mitral regurgitation. N Engl J Med (2013) 6.21
Surgical ablation of atrial fibrillation during mitral-valve surgery. N Engl J Med (2015) 4.77
Multiple loci influence erythrocyte phenotypes in the CHARGE Consortium. Nat Genet (2009) 4.28
Porphysome nanovesicles generated by porphyrin bilayers for use as multimodal biophotonic contrast agents. Nat Mater (2011) 3.40
Two-Year Outcomes of Surgical Treatment of Severe Ischemic Mitral Regurgitation. N Engl J Med (2015) 3.11
Autologous haemopoietic stem-cell transplantation followed by allogeneic or autologous haemopoietic stem-cell transplantation in patients with multiple myeloma (BMT CTN 0102): a phase 3 biological assignment trial. Lancet Oncol (2011) 2.78
Risk of pancreatic cancer in relation to ABO blood group and hepatitis C virus infection in Korea: a case-control study. J Korean Med Sci (2013) 2.23
Activatable photosensitizers for imaging and therapy. Chem Rev (2010) 2.23
Prognosis of negative adenosine stress magnetic resonance in patients presenting to an emergency department with chest pain. J Am Coll Cardiol (2006) 2.08
Transmission/disequilibrium test based on haplotype sharing for tightly linked markers. Am J Hum Genet (2003) 1.84
Transcriptional profiling of bone regeneration. Insight into the molecular complexity of wound repair. J Biol Chem (2002) 1.73
Statistical design of personalized medicine interventions: the Clarification of Optimal Anticoagulation through Genetics (COAG) trial. Trials (2010) 1.72
Linkage disequilibrium mapping of quantitative-trait Loci by selective genotyping. Am J Hum Genet (2005) 1.64
Wedge bronchoplastic lobectomy for non-small cell lung cancer as an alternative to sleeve lobectomy. J Thorac Cardiovasc Surg (2011) 1.53
Severity and timing of progression predict refractoriness to transarterial chemoembolization in hepatocellular carcinoma. J Gastroenterol Hepatol (2012) 1.48
Efficient approximation of P-value of the maximum of correlated tests, with applications to genome-wide association studies. Ann Hum Genet (2008) 1.46
Testing association for markers on the X chromosome. Genet Epidemiol (2007) 1.43
Notch activation promotes cell proliferation and the formation of neural stem cell-like colonies in human glioma cells. Mol Cell Biochem (2007) 1.41
Angiographic changes in saphenous vein grafts are predictors of clinical outcomes. Am Heart J (2003) 1.41
Lipoprotein-inspired nanoparticles for cancer theranostics. Acc Chem Res (2011) 1.30
Investigating the impact of nanoparticle size on active and passive tumor targeting efficiency. ACS Nano (2014) 1.23
Site-specific risk factors for colorectal cancer in a Korean population. PLoS One (2011) 1.21
Prospective alpha allocation in the Clarification of Optimal Anticoagulation through Genetics (COAG) trial. Clin Trials (2010) 1.18
Pyropheophorbide 2-deoxyglucosamide: a new photosensitizer targeting glucose transporters. Bioconjug Chem (2003) 1.17
HDL-mimicking peptide-lipid nanoparticles with improved tumor targeting. Small (2010) 1.17
Intrinsically copper-64-labeled organic nanoparticles as radiotracers. Angew Chem Int Ed Engl (2012) 1.16
A robust genome-wide scan statistic of the Wellcome Trust Case-Control Consortium. Biometrics (2009) 1.15
Porphyrin shell microbubbles with intrinsic ultrasound and photoacoustic properties. J Am Chem Soc (2012) 1.14
Rationale and design of the Clarification of Optimal Anticoagulation through Genetics trial. Am Heart J (2013) 1.12
Venous blood ammonia can be associated with cerebral blood flow in hepatic encephalopathy. Hepatology (2013) 1.12
Metabolic imaging of tumors using intrinsic and extrinsic fluorescent markers. Biosens Bioelectron (2004) 1.10
Tests of association between quantitative traits and haplotypes in a reduced-dimensional space. Ann Hum Genet (2005) 1.09
Low-density lipoprotein nanoparticles as magnetic resonance imaging contrast agents. Neoplasia (2006) 1.09
MAX-rank: a simple and robust genome-wide scan for case-control association studies. Hum Genet (2008) 1.08
Peptide-based pharmacomodulation of a cancer-targeted optical imaging and photodynamic therapy agent. Bioconjug Chem (2007) 1.07
Enzymatic regioselection for the synthesis and biodegradation of porphysome nanovesicles. Angew Chem Int Ed Engl (2012) 1.06
Heart failure as an endpoint in heart failure and non-heart failure cardiovascular clinical trials: the need for a consensus definition. Eur Heart J (2008) 1.05
Redox ratio of mitochondria as an indicator for the response of photodynamic therapy. J Biomed Opt (2004) 1.04
Altered brain functional connectivity in patients with cirrhosis and minimal hepatic encephalopathy: a functional MR imaging study. Radiology (2012) 1.04
Multistage sampling for genetic studies. Annu Rev Genomics Hum Genet (2007) 1.04
Ectopic expression of Delta4 impairs hematopoietic development and leads to lymphoproliferative disease. Blood (2002) 1.01
Improving power for testing genetic association in case-control studies by reducing the alternative space. Biometrics (2009) 1.01
Manganese induces dopaminergic neurodegeneration via microglial activation in a rat model of manganism. Toxicol Sci (2008) 1.01
High-throughput functional microRNAs profiling by recombinant AAV-based microRNA sensor arrays. PLoS One (2012) 1.01
Ligand conjugated low-density lipoprotein nanoparticles for enhanced optical cancer imaging in vivo. J Am Chem Soc (2007) 1.00
Efficiency robust statistics for genetic linkage and association studies under genetic model uncertainty. Stat Med (2010) 1.00
Robust trend tests for genetic association in case-control studies using family data. BMC Genet (2005) 0.99
Robust tests for single-marker analysis in case-control genetic association studies. Ann Hum Genet (2009) 0.99
Lipoprotein nanoplatform for targeted delivery of diagnostic and therapeutic agents. Mol Imaging (2008) 0.98
Characterizing the metabolic heterogeneity in human breast cancer xenografts by 3D high resolution fluorescence imaging. Springerplus (2013) 0.98
High volumetric breast density predicts risk for breast cancer in postmenopausal, but not premenopausal, Korean Women. Ann Surg Oncol (2014) 0.97
Efficient cytosolic delivery of siRNA using HDL-mimicking nanoparticles. Small (2011) 0.97
Biomimetic nanocarrier for direct cytosolic drug delivery. Angew Chem Int Ed Engl (2009) 0.97
Ablation of hypoxic tumors with dose-equivalent photothermal, but not photodynamic, therapy using a nanostructured porphyrin assembly. ACS Nano (2013) 0.97
Joint analysis of binary and quantitative traits with data sharing and outcome-dependent sampling. Genet Epidemiol (2012) 0.96
Analysis of treatment outcomes of intraventricular chemotherapy in 105 patients for leptomeningeal carcinomatosis from non-small-cell lung cancer. J Thorac Oncol (2013) 0.95
Iron supplement prevents lead-induced disruption of the blood-brain barrier during rat development. Toxicol Appl Pharmacol (2006) 0.95
Multimodal bacteriochlorophyll theranostic agent. Theranostics (2011) 0.95
Altered regional homogeneity in the development of minimal hepatic encephalopathy: a resting-state functional MRI study. PLoS One (2012) 0.95
When to stop a clinical trial early for benefit: lessons learned and future approaches. Circ Heart Fail (2012) 0.95
Near-infrared optical imaging of B16 melanoma cells via low-density lipoprotein-mediated uptake and delivery of high emission dipole strength tris[(porphinato)zinc(II)] fluorophores. Bioconjug Chem (2005) 0.95
Structural and functional abnormalities of default mode network in minimal hepatic encephalopathy: a study combining DTI and fMRI. PLoS One (2012) 0.95
Effect of HER-2/neu over-expression on prognosis in gastric cancer: a meta-analysis. Asian Pac J Cancer Prev (2011) 0.94
Establishment of an AAV reverse infection-based array. PLoS One (2010) 0.94
Prognostic implications of genetic variants in advanced non-small cell lung cancer: a genome-wide association study. Carcinogenesis (2012) 0.94
Transforming a Targeted Porphyrin Theranostic Agent into a PET Imaging Probe for Cancer. Theranostics (2011) 0.94
Pearson's test, trend test, and MAX are all trend tests with different types of scores. Ann Hum Genet (2009) 0.93
The effect of hepatic encephalopathy, hepatic failure, and portosystemic shunt on brain volume of cirrhotic patients: a voxel-based morphometry study. PLoS One (2012) 0.93
High payload delivery of optical imaging and photodynamic therapy agents to tumors using phthalocyanine-reconstituted low-density lipoprotein nanoparticles. J Biomed Opt (2005) 0.93
Targeting-triggered porphysome nanostructure disruption for activatable photodynamic therapy. Adv Healthc Mater (2014) 0.92
Synthesis and evaluation of a stable bacteriochlorophyll-analog and its incorporation into high-density lipoprotein nanoparticles for tumor imaging. Bioconjug Chem (2009) 0.92
Risk for leptomeningeal seeding after resection for brain metastases: implication of tumor location with mode of resection. J Neurosurg (2012) 0.92
Metal nanoparticle decorated n-type Bi₂Te₃-based materials with enhanced thermoelectric performances. Nanotechnology (2013) 0.92
Designing comparative effectiveness trials of surgical ablation for atrial fibrillation: experience of the Cardiothoracic Surgical Trials Network. J Thorac Cardiovasc Surg (2011) 0.92
Worse outcome of sorafenib therapy associated with ascites and Child-Pugh score in advanced hepatocellular carcinoma. J Gastroenterol Hepatol (2013) 0.92
In vivo detection of phospholipase C by enzyme-activated near-infrared probes. Bioconjug Chem (2011) 0.92
A robust test for two-stage design in genome-wide association studies. Biometrics (2009) 0.91
Biomarker-guided therapies in heart failure: a forum for unified strategies. J Card Fail (2013) 0.91
Protease-triggered photosensitizing beacon based on singlet oxygen quenching and activation. J Am Chem Soc (2004) 0.91
Carbocyanine labeled LDL for optical imaging of tumors. Acad Radiol (2004) 0.91
FRET quenching of photosensitizer singlet oxygen generation. J Phys Chem B (2009) 0.91
Rank-based robust tests for quantitative-trait genetic association studies. Genet Epidemiol (2013) 0.91
Genetic association with multiple traits in the presence of population stratification. Genet Epidemiol (2013) 0.90
Effect of microglia activation on dopaminergic neuronal injury induced by manganese, and its possible mechanism. Neurotox Res (2009) 0.90
In situ polymerized superhydrophobic and superoleophilic nanofibrous membranes for gravity driven oil-water separation. Nanoscale (2013) 0.90
Accuracy of IgM antibody testing, FQ-PCR and culture in laboratory diagnosis of acute infection by Mycoplasma pneumoniae in adults and adolescents with community-acquired pneumonia. BMC Infect Dis (2013) 0.90
Naphthalocyanine-reconstituted LDL nanoparticles for in vivo cancer imaging and treatment. Int J Nanomedicine (2007) 0.90
Self-assembled porphyrin nanodiscs with structure-dependent activation for phototherapy and photodiagnostic applications. ACS Nano (2013) 0.90
Robust genomic control and robust delta centralization tests for case-control association studies. Hum Hered (2007) 0.90
Self-assembling peptide-based nanoparticles enhance cellular delivery of the hydrophobic anticancer drug ellipticine through caveolae-dependent endocytosis. Nanomedicine (2011) 0.90
Conditional linkage and genome-wide association studies identify UGT1A1 as a major gene for anti-atherogenic serum bilirubin levels--the Framingham Heart Study. Atherosclerosis (2009) 0.90
Killer beacons for combined cancer imaging and therapy. Curr Med Chem (2007) 0.90